Bolt Biotherapeutics (BOLT) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to -$53.0 million.
- Bolt Biotherapeutics' Enterprise Value rose 156.33% to -$53.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.0 million, marking a year-over-year increase of 156.33%. This contributed to the annual value of -$47.3 million for FY2024, which is 5369.07% up from last year.
- Latest data reveals that Bolt Biotherapeutics reported Enterprise Value of -$53.0 million as of Q3 2025, which was up 156.33% from -$73.7 million recorded in Q2 2025.
- In the past 5 years, Bolt Biotherapeutics' Enterprise Value registered a high of -$47.3 million during Q4 2024, and its lowest value of -$266.7 million during Q1 2021.
- For the 5-year period, Bolt Biotherapeutics' Enterprise Value averaged around -$135.4 million, with its median value being -$125.9 million (2023).
- In the last 5 years, Bolt Biotherapeutics' Enterprise Value plummeted by 219609.95% in 2021 and then soared by 5506.5% in 2024.
- Over the past 5 years, Bolt Biotherapeutics' Enterprise Value (Quarter) stood at -$186.2 million in 2021, then grew by 9.31% to -$168.9 million in 2022, then surged by 39.49% to -$102.2 million in 2023, then surged by 53.69% to -$47.3 million in 2024, then decreased by 11.91% to -$53.0 million in 2025.
- Its Enterprise Value was -$53.0 million in Q3 2025, compared to -$73.7 million in Q2 2025 and -$88.4 million in Q1 2025.